MET and cancer: On the other hand, hepatocyte growth factor (HGF), produced by cancer-associated fibroblasts (CAFs) and mesenchymal stromal cells (MSCs), triggers the mesenchymal-epithelial transition (c-MET) receptor tyrosine kinase (RTK) predominantly found on c-MET+ cancer cells and MDSCs.